Event Notification Report for July 17, 2015
U.S. Nuclear Regulatory Commission
Operations Center
EVENT REPORTS FOR
07/16/2015 - 07/17/2015
EVENT NUMBERS
51251
Agreement State
Event Number: 51251
Rep Org: GEORGIA RADIOACTIVE MATERIAL PGM
Licensee: RADIOTHERAPY CLINICS OF GEORGIA
Region: 1
City: LAWRENCEVILLE State: GA
County:
License #:
Agreement: Y
Docket:
NRC Notified By: TRAVIS CARTOSKI
HQ OPS Officer: MARK ABRAMOVITZ
Licensee: RADIOTHERAPY CLINICS OF GEORGIA
Region: 1
City: LAWRENCEVILLE State: GA
County:
License #:
Agreement: Y
Docket:
NRC Notified By: TRAVIS CARTOSKI
HQ OPS Officer: MARK ABRAMOVITZ
Notification Date: 07/22/2015
Notification Time: 15:20 [ET]
Event Date: 07/17/2015
Event Time: 00:00 [EDT]
Last Update Date: 07/22/2015
Notification Time: 15:20 [ET]
Event Date: 07/17/2015
Event Time: 00:00 [EDT]
Last Update Date: 07/22/2015
Emergency Class: NON EMERGENCY
10 CFR Section:
10 CFR Section:
Person (Organization):
SILAS KENNEDY (R1DO)
NMSS_EVENTS_NOTIFICA (EMAI)
SILAS KENNEDY (R1DO)
NMSS_EVENTS_NOTIFICA (EMAI)
AGREEMENT STATE REPORT - MEDICAL OVERDOSE FOR SKIN CANCER
The following report was received via e-mail:
"1. A patient received an [Ir-192] HDR treatment using a skin applicator on the nose. This treatment is used to treat skin cancer.
"2. The physician's written directive specified a dose to the tumor volume, and a maximum tumor dose of 130 percent of the prescribed dose. The total dose was delivered in 8 fractions.
"3. The patient's course of treatment proceeded to conclusion. On recent follow-up exam, the patient's skin reaction was more than usual for this type of treatment, so the physician asked physics to review the plan.
"4. This review indicated the tumor volume maximum dose exceeded the prescribed 130 percent by more than 50 percent."
The date, time, and dose prescribed/received were not given in the report.
A Medical Event may indicate potential problems in a medical facility's use of radioactive materials. It does not necessarily result in harm to the patient.
The following report was received via e-mail:
"1. A patient received an [Ir-192] HDR treatment using a skin applicator on the nose. This treatment is used to treat skin cancer.
"2. The physician's written directive specified a dose to the tumor volume, and a maximum tumor dose of 130 percent of the prescribed dose. The total dose was delivered in 8 fractions.
"3. The patient's course of treatment proceeded to conclusion. On recent follow-up exam, the patient's skin reaction was more than usual for this type of treatment, so the physician asked physics to review the plan.
"4. This review indicated the tumor volume maximum dose exceeded the prescribed 130 percent by more than 50 percent."
The date, time, and dose prescribed/received were not given in the report.
A Medical Event may indicate potential problems in a medical facility's use of radioactive materials. It does not necessarily result in harm to the patient.